Popular Post

Posted by : Unknown Thursday, May 15, 2014



Salbutamol, Ventolin, Ventolin Rotocaps, Volmax
Action:
Synthetic sympathomimetic amine and moderately selective beta2-adrenergic agonist with comparatively long action. Acts more prominently on beta2 receptors (particularly smooth muscles of bronchi, uterus, and vascular supply to skeletal muscles) than on beta1 (heart) receptors. Minimal or no effect on alpha-adrenergic receptors. Inhibits histamine release by mast cells.
Classifications:
autonomic nervous system agent; beta-adrenergic agonist (sympathomimetic); bronchodilator (respiratory smooth muscle relaxant)
Indication:
To relieve bronchospasm associated with acute or chronic asthma, bronchitis, or other reversible obstructive airway diseases. Also used to prevent exercise-induced bronchospasm.
TABLE
Drug Name
Dosage & Route
Action
Indication
Adverse Effects
Contraindication
Nursing Responsibility


ALBUTEROL
(al-byoo'ter-ole))

Accuneb, Novosalmol , Proventil, Proventil HFA, Proventil Repetabs, Salbutamol, Ventolin, Ventolin Rotocaps, Volmax

Classifications: autonomic nervous system agent; beta-adrenergic agonist (sympathomimetic); bronchodilator (respiratory smooth muscle relaxant)












Bronchospasm
Adult: PO 2–4 mg 3–4 times/d, 4–8 mg sustained release 2 times/d Inhaled 1–2 inhalations q4–6h
Child: PO 2–6 y, 0.1–0.2 mg/kg t.i.d. (max: 4 mg/dose); 6–12 y, 2 mg 3–4 times/d; Inhaled 6–12 y, 1–2 inhalations q4–6h

Synthetic sympathomimetic amine and moderately selective beta2-adrenergic agonist with comparatively long action. Acts more prominently on beta2 receptors (particularly smooth muscles of bronchi, uterus, and vascular supply to skeletal muscles) than on beta1 (heart) receptors. Minimal or no effect on alpha-adrenergic receptors. Inhibits histamine release by mast cells.

To relieve bronchospasm associated with acute or chronic asthma, bronchitis, or other reversible obstructive airway diseases. Also used to prevent exercise-induced bronchospasm.


Body as a Whole: Hypersensitivity reaction. CNS: Tremor, anxiety, nervousness, restlessness, convulsions, weakness, headache, hallucinations. CV: Palpitation, hypertension, hypotension, bradycardia, reflex tachycardia. Special Senses: Blurred vision, dilated pupils. GI: Nausea, vomiting. Other: Muscle cramps, hoarseness.

Pregnancy (category C), lactation. Use of oral syrup in children <2 y.

Assessment & Drug Effects
  • Monitor therapeutic effectiveness which is indicated by significant subjective improvement in pulmonary function within 60–90 min after drug administration.
  • Monitor for: S&S of fine tremor in fingers, which may interfere with precision handwork; CNS stimulation, particularly in children 2–6 y, (hyperactivity, excitement, nervousness, insomnia), tachycardia, GI symptoms. Report promptly to physician.
  • Lab tests: Periodic ABGs, pulmonary functions, and pulse oximetry.
  • Consult physician about giving last albuterol dose several hours before bedtime, if drug-induced insomnia is a problem.


Leave a Reply

Subscribe to Posts | Subscribe to Comments

Copyright © toscamalonzo - Created by